Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

AIMS: To determine whether IHC4 score assessed on pre-treatment core biopsies (i) predicts response to neo-adjuvant chemotherapy in ER-positive (ER+) breast cancer; (ii) provides more predictive information than Ki67 alone. METHODS: 113 patients with ER+ primary breast cancer treated with neo-adjuva...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Main Authors: Sheri, A., Smith, I. E., Hills, M., Jones, R. L., Johnston, S. R., Dowsett, M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2017
Assuntos:
Clinical Trial
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487724/
https://ncbi.nlm.nih.gov/pubmed/28447240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4266-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares